FDA Moves to Reevaluate Several Peptides American Med Spa Association FDA Drug Recalls and Warnings: Recalls for Compounded Semaglutide and Tirzepatide, Wegovy; Facility Warning Letters MedShadow Foundation RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York August 11, 2025: The FDA voices concern about sites that supply compounding ingredients Partnership for Safe Medicines